AzTrials
AzTrials

Acute CholecystitisNCT02130245

Acute Cholecystitis: Early Versus Delayed Laparoscopic Cholecystectomy; Randomized Prospective Study

A study testing Early cholecystectomy and Delayed cholecystectomy in people with Acute Cholecystitis, run by Mansoura University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The best management of the acute cholecystitis is to do laparoscopic cholecystectomy. The hypothesis is that to do it as an early intervention after patient admission is better than delayed cholecystectomy regarding the hospital stay, interval for antibiotic, the easiness of the operative maneuver reflected by… Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Acute Cholecystitis
What is being tested?
Early cholecystectomy and Delayed cholecystectomy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
600 participants
Where
1 siteEgypt
Study dates
Sep 2013to Jan 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Proved acute cholecystitis clinical, radiologic

Who cannot join

  • Evidence of peritonitis
  • ASA III or IV
  • Previous upper abdominal surgery
  • Pregnancy

Trial locations and contacts

1 site in 1 country.

mohamed e abdellatif, md contact

00201115051680

surg_latif@hotmail.com

Egypt1 site, 1 recruiting
  • mansoura university hospital, EGYPT, central hafr elbatin hospital, Saudia Arabia

    Al Mansurah

    mohamed E abd ellatif, PhD, 00966543973660, SURG_LATIF@HOTMAIL.COM

    MOHAMED E ABD ELLATIF, PHD

    Recruiting

Other trials in Egypt

About this study

The best management of the acute cholecystitis is to do laparoscopic cholecystectomy. The hypothesis is that to do it as an early intervention after patient admission is better than delayed cholecystectomy regarding the hospital stay, interval for antibiotic, the easiness of the operative maneuver reflected by operative time, conversion and intraoperative complications.

Read the detailed description

Doing laparoscopic cholecystectomy for patients with acute cholecystitis as an early intervention after patient admission ( first group) or to do it after a while of treatment and conservation as a delayed cholecystectomy (second group) points of study include the hospital stay, interval for antibiotic, the easiness of the operative maneuver reflected by operative time, conversion and intraoperative complications.

Being tested
Early cholecystectomy, Delayed cholecystectomy
Keywords
Laparoscopic cholecystectomy, Acute cholecystitis, Early, Delayed
Medical subject headings
Cholecystitis, Acute

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Early cholecystectomyProcedure or surgery

    Also called First group

    Early laparoscopic cholecystectomy for acute cholecystitis after admission

  • Delayed cholecystectomyProcedure or surgery

    Also called Second group

    Laparoscopic cholecystectomy well be done after a period on conservation

Study groups in NCT02130245
Study groupRoleWhat they receive
Early cholecystectomyActive comparatorLaparoscopic cholecystectomy well be done after the immediate admission
Receives: Procedure: Early cholecystectomy
Delayed cholecystectomyActive comparatorLaparoscopic cholecystectomy after a period of conservative treatment
Receives: Procedure: Delayed cholecystectomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Operative time

    Operative time is assessed in minutes ,

    Measured: 1 DAY

Secondary outcomes (4)
  1. Perioperative complications

    Intraoperative complications like bleeding , injury,

    Measured: 5 weeks

  2. Conversion rate

    Conversion rate from laparoscopic to open and reason of conversion.

    Measured: 1 DAY

  3. hospital stay in days

    hospital stay in days

    Measured: 2 weeks

  4. Period of giving antibiotics in days

    Number of days giving the antibiotics

    Measured: 2 WEEKS

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 May 2014 (estimated)
  2. Study startSep 2013
  3. Primary completionJan 2016 (estimated)
  4. Study completionJan 2016 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
600 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02130245
Sponsor's protocol ID
Early cholecystectomy
Status last verified
Apr 2015
First submitted
21 Apr 2014
Last updated
8 Apr 2015
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Early cholecystectomy and Delayed cholecystectomy in people with Acute Cholecystitis, run by Mansoura University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 8 Apr 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact mohamed e abdellatif, md (00201115051680, surg_latif@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Operative time (time frame: 1 DAY). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Apr 2015.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in